Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 3
2006 17
2007 21
2008 27
2009 27
2010 24
2011 22
2012 26
2013 20
2014 32
2015 35
2016 30
2017 33
2018 26
2019 24
2020 31
2021 35
2022 24
2023 19
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

437 results

Results by year

Filters applied: . Clear all
Page 1
Antibacterial Ingredients and Modes of the Methanol-Phase Extract from the Fruit of Amomum villosum Lour.
Zhang K, Cao F, Zhao Y, Wang H, Chen L. Zhang K, et al. Plants (Basel). 2024 Mar 14;13(6):834. doi: 10.3390/plants13060834. Plants (Basel). 2024. PMID: 38592864 Free PMC article.
Eighty-nine compounds in Fraction 2 were identified by ultra HPLC-mass spectrometry (UHPLC-MS) analysis, among which 4-hydroxyphenylacetylglutamic acid accounted for the highest 30.89%, followed by lubiprostone (11.86%), miltirone (10.68%), and oleic acid (10.58%). Compara …
Eighty-nine compounds in Fraction 2 were identified by ultra HPLC-mass spectrometry (UHPLC-MS) analysis, among which 4-hydroxyphenylacetylgl …
Ecotoxicological impact of naproxen on Eisenia fetida: Unraveling soil contamination risks and the modulating role of microplastics.
Zhang L, Wang D, Yuan J, Chen J, Ding T, Zhu T, Li J. Zhang L, et al. Sci Total Environ. 2024 Jun 10;928:172267. doi: 10.1016/j.scitotenv.2024.172267. Epub 2024 Apr 5. Sci Total Environ. 2024. PMID: 38583628
The detection of numerous including lipids like 17-Hydroxyandrostane-3-glucuronide, lubiprostone, morroniside, and phosphorylcholine, serves to identify potential biomarkers for naproxen and microplastics exposure. ...
The detection of numerous including lipids like 17-Hydroxyandrostane-3-glucuronide, lubiprostone, morroniside, and phosphorylcholine, …
Role of gut-derived bacterial lipopolysaccharide and peripheral TLR4 in immobilization stress-induced itch aggravation in a mouse model of atopic dermatitis.
Cho DE, Hong JP, Kim Y, Sim JY, Kim HS, Kim SR, Lee B, Cho HS, Cho IH, Shin S, Yeom M, Kwon SK, Lee IS, Park H, Kim K, Hahm DH. Cho DE, et al. Sci Rep. 2024 Mar 15;14(1):6263. doi: 10.1038/s41598-024-56936-z. Sci Rep. 2024. PMID: 38491103 Free PMC article.
Oral antibiotics or intestinal permeability blockers, such as lubiprostone (Lu), 2,4,6-triaminopyrimidine (TAP) and ML-7, inhibited IMO stress-associated itch; however, it was reinduced through intradermal or i.p. injection of LPS without IMO stress. ...
Oral antibiotics or intestinal permeability blockers, such as lubiprostone (Lu), 2,4,6-triaminopyrimidine (TAP) and ML-7, inhibited I …
Efficacy of lubiprostone for functional constipation treatment in adolescents and children: Randomized controlled trial.
Elkaragy ES, Shamseya MM, Metwally RH, Mansour ER, Lashen SA. Elkaragy ES, et al. J Pediatr Gastroenterol Nutr. 2024 Apr;78(4):800-809. doi: 10.1002/jpn3.12135. Epub 2024 Feb 5. J Pediatr Gastroenterol Nutr. 2024. PMID: 38314885 Clinical Trial.
OBJECTIVES: Adolescent and pediatric functional constipation (FC) is a common clinical problem. Currently, data on lubiprostone for the treatment of pediatric FC are scarce. This study investigated the efficacy and safety of lubiprostone in the treatment of pediatri …
OBJECTIVES: Adolescent and pediatric functional constipation (FC) is a common clinical problem. Currently, data on lubiprostone for t …
Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat/harm.
Rao SS, Manabe N, Karasawa Y, Hasebe Y, Nozawa K, Nakajima A, Fukudo S. Rao SS, et al. BMC Gastroenterol. 2024 Jan 2;24(1):12. doi: 10.1186/s12876-023-03104-8. BMC Gastroenterol. 2024. PMID: 38166671 Free PMC article.
OBJECTIVE: To comprehensively evaluate the efficacy, safety, patient symptoms, and quality-of-life (QoL) of lubiprostone, linaclotide, and elobixibat as treatment for chronic constipation (CC). ...However, the NNH analysis revealed distinct safety profiles: lubiprostone …
OBJECTIVE: To comprehensively evaluate the efficacy, safety, patient symptoms, and quality-of-life (QoL) of lubiprostone, linaclotide …
Recommendations for the management of opioid-induced constipation - how to improve usability in clinical practice.
Okdahl T, Emmanuel A, Morlion B, Farmer A, Varrassi G, Drewes AM. Okdahl T, et al. Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(10):975-983. doi: 10.1080/17474124.2023.2267441. Epub 2023 Oct 24. Expert Rev Gastroenterol Hepatol. 2023. PMID: 37822210 Review.
EXPERT OPINION: Despite standard treatment with laxatives and fluid intake in patients with opioid-induced constipation, escalation of treatment is often needed where mu-opioid receptor antagonists or newer medications such as lubiprostone, linaclotide, or prucalopride are …
EXPERT OPINION: Despite standard treatment with laxatives and fluid intake in patients with opioid-induced constipation, escalation of treat …
Constipation in Patients With Chronic Kidney Disease.
Cha RR, Park SY, Camilleri M; Constipation Research Group of Korean Society of Neurogastroenterology and Motility. Cha RR, et al. J Neurogastroenterol Motil. 2023 Oct 30;29(4):428-435. doi: 10.5056/jnm23133. J Neurogastroenterol Motil. 2023. PMID: 37814433 Free PMC article. Review.
The use of laxatives containing magnesium salts, bulking agents, and osmotic laxatives may have insufficient efficacy and may be associated with adverse effects. In contrast, lactulose and lubiprostone have been shown to exhibit reno-protective effects. Linaclotide and ple …
The use of laxatives containing magnesium salts, bulking agents, and osmotic laxatives may have insufficient efficacy and may be associated …
Lubiprostone plus polyethylene glycol electrolyte lavage solution (PEG-ELS) versus PEG-ELS for bowel preparation in chronic constipation: a randomized controlled trial.
Tangvoraphonkchai K, Manasirisuk W, Sawadpanich K, Suttichaimongkol T, Mairiang P. Tangvoraphonkchai K, et al. Sci Rep. 2023 Sep 27;13(1):16265. doi: 10.1038/s41598-023-43598-6. Sci Rep. 2023. PMID: 37759079 Free PMC article. Clinical Trial.
The rate of adequate bowel cleansing was comparable between the PEG-ELS plus lubiprostone group and the PEG-ELS alone group (50% vs. 52.9%, p value = 0.81) with a relative risk of 1.13 (95% CI = 0.43-2.91). ...No additional benefit to successful bowel preparation was achie …
The rate of adequate bowel cleansing was comparable between the PEG-ELS plus lubiprostone group and the PEG-ELS alone group (50% vs. …
437 results